REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $24,000 | +242.9% | 36,983 | +69.9% | 0.00% | – |
Q3 2017 | $7,000 | -30.0% | 21,773 | 0.0% | 0.00% | – |
Q2 2017 | $10,000 | -63.0% | 21,773 | -3.0% | 0.00% | – |
Q1 2017 | $27,000 | -6.9% | 22,446 | +3.1% | 0.00% | – |
Q4 2016 | $29,000 | -39.6% | 21,773 | -6.1% | 0.00% | – |
Q3 2016 | $48,000 | +9.1% | 23,176 | -14.8% | 0.00% | – |
Q2 2016 | $44,000 | +69.2% | 27,199 | 0.0% | 0.00% | – |
Q1 2016 | $26,000 | -21.2% | 27,199 | 0.0% | 0.00% | – |
Q4 2015 | $33,000 | -91.8% | 27,199 | -49.6% | 0.00% | – |
Q3 2015 | $401,000 | +17.3% | 54,010 | +12.7% | 0.00% | – |
Q2 2015 | $342,000 | -72.6% | 47,917 | -67.0% | 0.00% | – |
Q1 2015 | $1,246,000 | -6.5% | 145,131 | +8.6% | 0.00% | – |
Q4 2014 | $1,332,000 | +6.6% | 133,578 | +5.8% | 0.00% | – |
Q3 2014 | $1,249,000 | -69.1% | 126,205 | -46.0% | 0.00% | -100.0% |
Q2 2014 | $4,040,000 | +85.2% | 233,592 | +90.0% | 0.00% | 0.0% |
Q1 2014 | $2,182,000 | -2.0% | 122,964 | +1.0% | 0.00% | 0.0% |
Q4 2013 | $2,227,000 | -70.0% | 121,714 | -56.1% | 0.00% | 0.0% |
Q3 2013 | $7,422,000 | +301.6% | 276,950 | +176.4% | 0.00% | 0.0% |
Q2 2013 | $1,848,000 | – | 100,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $11,210,000 | 4.33% |
DESTRIER CAPITAL MANAGEMENT LLC | 933,600 | $9,243,000 | 2.32% |
SENZAR ASSET MANAGEMENT, LLC | 753,600 | $7,460,000 | 2.19% |
ORACLE INVESTMENT MANAGEMENT INC | 1,014,164 | $10,040,000 | 1.39% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 775,307 | $7,675,000 | 0.50% |
Trellus Management Company, LLC | 50,000 | $495,000 | 0.42% |
FNY Managed Accounts LLC | 14,000 | $138,600,000 | 0.42% |
GENERAL AMERICAN INVESTORS CO INC | 449,475 | $4,450,000 | 0.36% |
Baker Brothers Advisors | 2,778,654 | $27,509,000 | 0.35% |
CQS Cayman LP | 550,000 | $5,445,000 | 0.32% |